Primary Record
oxaprozin
- In stock
- 4,649 g
- Purity
- 98.5 %
- CAS
- 21256-18-8
Compound Identifiers & Properties
- CAS
- 21256-18-8
- PubChem CID
- 4614
- SMILES
- C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
- Canonical SMILES
- O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1
Names & Synonyms
- oxaprozin
- Daypro
- Alvo
- 21256-18-8
- Oxaprozinum
- Oxaprozine
- Deflam
- Oxaprozina
- Voir
- Danoprox
- Duraprox
- Dayrun
- Actirin
- Xopane
- Apo Oxaprozin
- Apo-Oxaprozin
- Rhoxal oxaprozin
- Rhoxal-oxaprozin
- oxaprosin
- Allcerozin
- Okinesujin
- Olosaruzin
- Duraprost
- Inamizin
- Ocefazine
- Oxachilin
- Oxaprozi
- Oxyacidon
- Papirzin
- Salbonat
- Durapro
- Oxapro
- Walix
- 3-(4,5-Diphenyloxazol-2-yl)propanoic acid
- COXANTO
- Daypro Alta
- 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid
- Oxaprozin, solid
- Oxaprozine [INN-French]
- Oxaprozinum [INN-Latin]
- Oxaprozina [INN-Spanish]
- Daypro (TN)
- lyl)propenoic acid
- Oxaprozin Potassium
- Oxaprozinum;Wy21743
- 4,5-Diphenyl-2-oxazolepropionic acid
- Duraprox (TN)
- 4,5-Diphenyl-2-oxazolepropanoic acid
- MHJ80W9LRB
- Oxaprozin (Standard)
- WY-21743
- C18H15NO3
- CSC brand of oxaprozin
- TRB brand of oxaprozin
- WY-21,743
- OXAPROZIN [INN]
- OXAPROZIN [JAN]
- RefChem:56403
- 2-Oxazolepropanoic acid, 4,5-diphenyl-
- DTXSID1045118
- OXAPROZIN [MI]
- MFCD00215977
- OXAPROZIN [HSDB]
- OXAPROZIN [USAN]
- Apotex brand of oxaprozin
- Maybridge1_008800
- Pfizer brand of oxaprozin
- Prestwick0_001060
- Prestwick1_001060
- Prestwick2_001060
- Prestwick3_001060
- Spectrum2_001696
- Spectrum3_001078
- Spectrum4_001231
- UNII-MHJ80W9LRB
- CHEMBL1071
- Lopac-O-9637
- OXAPROZIN [VANDF]
- OFPXSFXSNFPTHF-UHFFFAOYSA-N
- NSC310839
- D0M9DC
- OXAPROZIN [MART.]
- AC1L1IK7
- OXAPROZIN [USP-RS]
- OXAPROZIN [WHO-DD]
- SCHEMBL3286
- CHEBI:7822
- NCIStruc1_000799
- NCIStruc2_000787
- NSC-310839
- WY 21743
- BIDD:PXR0149
- Lopac0_000944
- Oprea1_509470
- BSPBio_001020
- BSPBio_002696
- DTXCID9025118
- KBioGR_001722
- MLS000759535
- MLS001424072
- BIDD:GT0438
- SPECTRUM1505267
- Oxaprozin - Bio-X trade mark
- SPBio_001652
- SPBio_002940
- 3-(diphenyl-1,3-oxazol-2-yl)propanoic acid
- Oxaprozin (JP18/USP/INN)
- Oxaprozin [USAN:BAN:INN:JAN]
- Rhoxalpharma brand of oxaprozin
- AC1Q759J
- AC1Q759K
- BPBio1_001122
- GTPL7252
- orb1310364
- orb3025231
- 3-(4, 5-Diphenyl-2-oxazo
- Oxaprozin (JP15/USAN/INN)
- OXAPROZIN [ORANGE BOOK]
- NSC 310839
- CTK7J3117
- EINECS 244-296-1
- ERK5-2C03
- HMS566H22
- HSDB 7586
- HY-B0808R
- KBio3_001916
- KS-00000ULR
- CID4614
- M01AE12
- MSK7199
- OXAPROZIN [USP MONOGRAPH]
- beta-(4,5-Diphenyloxazol-2-yl)propionic acid
- NCI310839
- 3-(4,5-Diphenyl-2-oxazolyl)propenoic acid
- 4,5-Diphenyloxazole-2-propionic acid
- GLXC-23892
- HMS1571C22
- HMS1922P17
- HMS2051L15
- HMS2093O08
- HMS2098C22
- HMS3262N10
- HMS3393L15
- HMS3652H17
- HMS3715C22
- HMS3885L11
- HMS5082D16
- Pharmakon1600-01505267
- 4,5 Diphenyl 2 oxazolepropionic Acid
- Wy21743
- 4, 5-Diphenyl-2-oxazolepropionic acid
- AMY32551
- BCP28431
- CID:4614
- HY-B0808
- Wy 21,743
- BRN 1083168
- Tox21_110059
- Tox21_500944
- 2-Oxazolepropanoic acid,5-diphenyl-
- 2-Oxazolepropionic acid,5-diphenyl-
- ANW-63377
- BDBM50002861
- CCG-36508
- EBC-04209
- MSK7199-100M
- NCGC00014711
- NP3374
- NSC758949
- s4230
- SBB053166
- ZINC49643479
- 4,5-diphenyloxazole-2-propanoic acid
- AKOS000206807
- Oxaprozin (USAN:USP:INN:BAN:JAN)
- Oxaprozin [USAN:USP:INN:BAN:JAN]
- Tox21_110059_1
- CS-7975
- DB00991
- FO26614
- KS-5196
- LP00944
- NC00214
- NSC-758949
- SDCCGSBI-0050918.P004
- 2-OXAZOLEPROPIONIC ACID, 4,5-DIPHENYL-
- 3-(4,5-Diphenyl-2-oxazolyl)propionic acid
- CAS-21256-18-8
- .beta.-(4,5-Diphenyloxazol-2-yl)propionic acid
- NCGC00014711-01
- NCGC00014711-02
- NCGC00014711-03
- NCGC00014711-04
- NCGC00014711-05
- NCGC00014711-06
- NCGC00014711-07
- NCGC00014711-08
- NCGC00014711-09
- NCGC00014711-10
- NCGC00014711-11
- NCGC00014711-14
- NCGC00014711-15
- NCGC00094249-01
- NCGC00094249-02
- NCGC00094249-03
- NCGC00094249-04
- NCGC00094249-05
- NCGC00094249-06
- NCGC00094249-07
- NCGC00261629-01
- Oxaprozin 100 microg/mL in Acetonitrile
- AC-26512
- AJ-08102
- AK-84489
- BO164184
- CPD000058286
- J10.781F
- NCI60_002681
- SAM001246770
- SC-13926
- SMR000058286
- SY050819
- O 9637
- Oxaprozin Solution in Methanol, 100ug/mL
- SBI-0050918.P002
- SID:376229621
- AB0011812
- LS-100216
- TC-152122
- 3-(4,5-Diphenyl-2-oxazolyl)propanoic acid
- 3-(4,5-Diphenyloxazol-2-yl)propionic acid
- 3-(4,5-Diphenyloxazole-2-yl)propanoic acid
- AB00514024
- B1804
- EU-0100944
- FT-0638104
- NS00008254
- O0377
- ST50949623
- SW197319-4
- 3-(4, 5-Diphenyl-2-oxazolyl)propenoic acid
- EN300-25629
- 3-(4,5-Diphenyl-oxazol-2-yl)-propionic acid
- 4.5-Diphenyl-2-oxazolepropanoic acid|||Daypro
- C07356
- D00463
- J10396
- K-6109
- AB00514024_08
- AB00514024_09
- 256O188
- A815225
- C008729
- F066202
- SR-01000076053
- 1-AMINOCYCLOBUTANE-CIS-1,3-DICARBOXYLICACID
- I14-8703
- Q1749609
- SR-01000076053-1
- SR-01000076053-3
- SR-01000076053-7
- SR-01000076053-9
- 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid #
- BRD-K25394294-001-05-7
- BRD-K25394294-001-08-1
- BRD-K25394294-001-13-1
- BRD-K25394294-001-14-9
- D000077431
- Z212055564
- Oxaprozin, United States Pharmacopeia (USP) Reference Standard
- 244-296-1
- 4,5-diphenyl-2-Oxazolepropanoic acid; 2-Oxazolepropionic acid, 4,5-diphenyl- (8CI); 3-(4,5-Diphenyloxazol-2-yl)propionic acid; 4,5-Diphenyl-2-oxazolepropionic acid; Actirin; Alvo; Daypro; Durapro; Duraprost; NSC 310839; Oxapro; Oxaprozin; Wy 21743; beta-(4,5-Diphenyloxazol-2-yl)propionic acid
- BJ6
- Oxaprozin, 98%, a pancreatic and gastric lipase inhibitor and caspase-3 activator - 25G 25g